ArticleHormones (Athens, Greece)2026
Three-generation familial transmission of a GNAS variant: from gestational phenotype in the mother to evolving prenatal/neonatal phenotype in the offspring.
Article in Hormones (Athens, Greece), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDisorders caused by GNAS gene variants, including pseudohypoparathyroidism (PHP) types 1a, 1b and 1c, and pseudo-pseudohypoparathyroidism (PPHP), present with complex imprinting and phenotypic variability. The gene's parent-of-origin expression pattern results in diverse clinical manifestations. CASE PRESENTATION: We report a three-generation family harboring a heterozygous missense variant in GNAS (c.305 C > T, p.Ala102Val), classified as "likely pathogenic". The proband, a 29-year-old primigravida, and her mother displayed phenotypic features of Albright hereditary osteodystrophy (AHO) including short stature, brachydactyly, round face, and obesity. The proband was diagnosed with primary hypothyroidism at age 25. During pregnancy, her hormonal profile resembled PPHP rather than PHP 1a, with normocalcemia and elevated parathyroid hormone (PTH), potentially masked by pregnancy physiology. Her mother's phenotype was consistent with PPHP and exhibited elevated PTH due to vitamin D deficiency. The proband delivered a male neonate with normal birth parameters, but was later found to carry the familial GNAS variant. The neonate developed features of AHO, elevated PTH, and transient hypothyroidism, consistent with PHP 1a. Hormonal and calcium homeostasis remained stable with supplementation.
conclusionThis is, to the best of our knowledge, the first reported case of a three-generation family with a GNAS variant demonstrating an evolving phenotype during pregnancy and early life. Pregnancy-related physiological changes may counteract typical hormone resistance, complicating diagnosis. Our findings emphasize the importance of genetic counseling and longitudinal follow-up in GNAS-related disorders, particularly during reproductive planning and early infancy.
Indexed as
Identifiers
41222894What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.